Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leuka...
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
About this item
Full title
Author / Creator
Hallek, M, Prof , Fischer, K, MD , Fingerle-Rowson, G, MD , Fink, AM, MD , Busch, R , Mayer, J, Prof , Hensel, M, Prof , Hopfinger, G, MD , Hess, G, MD , von Grünhagen, U, MD , Bergmann, M, MD , Catalano, J, MD , Zinzani, PL, Prof , Caligaris-Cappio, F, Prof , Seymour, JF, Prof , Berrebi, A, Prof , Jäger, U, Prof , Cazin, B, MD , Trneny, M, MD , Westermann, A , Wendtner, CM, Prof , Eichhorst, BF, MD , Staib, P, MD , Bühler, A, MD , Winkler, D, MD , Zenz, T, MD , Böttcher, S, MD , Ritgen, M, MD , Mendila, M, MD , Kneba, M, Prof , Döhner, H, Prof , Stilgenbauer, S, Prof , on behalf of an international group of investigators , the German Chronic Lymphocytic Leukaemia Study Group , International Group of Investigators and German Chronic Lymphocytic Leukaemia Study Group
Publisher
Kidlington: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background On the basis of promising results that were reported in several phase 2 trials, we investigated whether the addition of the monoclonal antibody rituximab to first-line chemotherapy with fludarabine and cyclophosphamide would improve the outcome of patients with chronic lymphocytic leukaemia. Methods Treatment-naive, physically fi...
Alternative Titles
Full title
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Fischer, K, MD
Fingerle-Rowson, G, MD
Fink, AM, MD
Busch, R
Mayer, J, Prof
Hensel, M, Prof
Hopfinger, G, MD
Hess, G, MD
von Grünhagen, U, MD
Bergmann, M, MD
Catalano, J, MD
Zinzani, PL, Prof
Caligaris-Cappio, F, Prof
Seymour, JF, Prof
Berrebi, A, Prof
Jäger, U, Prof
Cazin, B, MD
Trneny, M, MD
Westermann, A
Wendtner, CM, Prof
Eichhorst, BF, MD
Staib, P, MD
Bühler, A, MD
Winkler, D, MD
Zenz, T, MD
Böttcher, S, MD
Ritgen, M, MD
Mendila, M, MD
Kneba, M, Prof
Döhner, H, Prof
Stilgenbauer, S, Prof
on behalf of an international group of investigators
the German Chronic Lymphocytic Leukaemia Study Group
International Group of Investigators
German Chronic Lymphocytic Leukaemia Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_756663828
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_756663828
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(10)61381-5
